Observes patients with heart failure using the WiSE System device
Watches how the WiSE device performs in adults with heart failure.
Plain-language title generated from the registry record
Registry title: The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
Key facts
- Where
- Ann Arbor, Austin, Charleston, Charlottesville, Cleveland, Hershey, Jonesboro, Kansas City, Mesa, Naples, New York, and Scottsdale, United StatesSee the 12 sites
Where in United States
- University of MichiganAnn Arbor, United StatesTaking people
- Texas Cardiac Arrhythmia Research FoundationAustin, United StatesTaking people
- MUSCCharleston, United StatesTaking people
- UVACharlottesville, United StatesTaking people
- Cleveland Clinic FoundationCleveland, United StatesTaking people
- Penn State HealthHershey, United StatesTaking people
- Arrhythmia Research Group (St. Bernards Hospital)Jonesboro, United StatesTaking people
- St. Luke's Hospital of Kansas CityKansas City, United StatesTaking people
- CardioVascular Associates of Mesa (CVAM)Mesa, United StatesTaking people
- Naples Community HospitalNaples, United StatesTaking people
- Weill Cornell MedicineNew York, United StatesTaking people
- Honor HealthScottsdale, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- EBR Systems, Inc.
- Trial code
- NCT07098858
- Record updated
- 16 October 2026
- Original description
Observe to understand product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE SystemRead full original descriptionShow less
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
Observe to understand product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE System
Patient or legally authorized representative can provide written authorization and/or consent per institution requirements; Patient is intended to receive a WiSE System and passed the acoustic window screening; Patient who is, or will be, accessible for follow-up; Participation is not excluded by local law; Patient is not enrolled in a concurrent drug and/or device study that may confound the Registry results; Patient life expectancy >1 year.